UniProt ID | AFG32_HUMAN | |
---|---|---|
UniProt AC | Q9Y4W6 | |
Protein Name | AFG3-like protein 2 | |
Gene Name | AFG3L2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 797 | |
Subcellular Localization |
Mitochondrion . Mitochondrion inner membrane Multi-pass membrane protein . |
|
Protein Description | ATP-dependent protease which is essential for axonal and neuron development. In neurons, mediates degradation of SMDT1/EMRE before its assembly with the uniporter complex, limiting the availability of SMDT1/EMRE for MCU assembly and promoting efficient assembly of gatekeeper subunits with MCU. [PubMed: 27642048 Required for the maturation of paraplegin (SPG7) after its cleavage by mitochondrial-processing peptidase (MPP), converting it into a proteolytically active mature form (By similarity] | |
Protein Sequence | MAHRCLRLWGRGGCWPRGLQQLLVPGGVGPGEQPCLRTLYRFVTTQARASRNSLLTDIIAAYQRFCSRPPKGFEKYFPNGKNGKKASEPKEVMGEKKESKPAATTRSSGGGGGGGGKRGGKKDDSHWWSRFQKGDIPWDDKDFRMFFLWTALFWGGVMFYLLLKRSGREITWKDFVNNYLSKGVVDRLEVVNKRFVRVTFTPGKTPVDGQYVWFNIGSVDTFERNLETLQQELGIEGENRVPVVYIAESDGSFLLSMLPTVLIIAFLLYTIRRGPAGIGRTGRGMGGLFSVGETTAKVLKDEIDVKFKDVAGCEEAKLEIMEFVNFLKNPKQYQDLGAKIPKGAILTGPPGTGKTLLAKATAGEANVPFITVSGSEFLEMFVGVGPARVRDLFALARKNAPCILFIDEIDAVGRKRGRGNFGGQSEQENTLNQLLVEMDGFNTTTNVVILAGTNRPDILDPALLRPGRFDRQIFIGPPDIKGRASIFKVHLRPLKLDSTLEKDKLARKLASLTPGFSGADVANVCNEAALIAARHLSDSINQKHFEQAIERVIGGLEKKTQVLQPEEKKTVAYHEAGHAVAGWYLEHADPLLKVSIIPRGKGLGYAQYLPKEQYLYTKEQLLDRMCMTLGGRVSEEIFFGRITTGAQDDLRKVTQSAYAQIVQFGMNEKVGQISFDLPRQGDMVLEKPYSEATARLIDDEVRILINDAYKRTVALLTEKKADVEKVALLLLEKEVLDKNDMVELLGPRPFAEKSTYEEFVEGTGSLDEDTSLPEGLKDWNKEREKEKEEPPGEKVAN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
14 | S-palmitoylation | RLWGRGGCWPRGLQQ HHHCCCCCCCCCHHH | 5.14 | 29575903 | |
99 | Phosphorylation | VMGEKKESKPAATTR HCCCCCCCCCCCCCC | 53.47 | 29083192 | |
100 | Acetylation | MGEKKESKPAATTRS CCCCCCCCCCCCCCC | 39.50 | 20167786 | |
104 | Phosphorylation | KESKPAATTRSSGGG CCCCCCCCCCCCCCC | 25.50 | 29083192 | |
105 | Phosphorylation | ESKPAATTRSSGGGG CCCCCCCCCCCCCCC | 24.67 | 29083192 | |
107 | Phosphorylation | KPAATTRSSGGGGGG CCCCCCCCCCCCCCC | 31.10 | 29083192 | |
108 | Phosphorylation | PAATTRSSGGGGGGG CCCCCCCCCCCCCCC | 37.86 | 29083192 | |
117 | Succinylation | GGGGGGGKRGGKKDD CCCCCCCCCCCCCCC | 51.66 | - | |
117 | Succinylation | GGGGGGGKRGGKKDD CCCCCCCCCCCCCCC | 51.66 | - | |
121 | Malonylation | GGGKRGGKKDDSHWW CCCCCCCCCCCCCCH | 56.72 | 30639696 | |
122 | Malonylation | GGKRGGKKDDSHWWS CCCCCCCCCCCCCHH | 70.78 | 26320211 | |
150 | Phosphorylation | FRMFFLWTALFWGGV HHHHHHHHHHHHHHH | 18.68 | 46160193 | |
160 | Phosphorylation | FWGGVMFYLLLKRSG HHHHHHHHHHHHHCC | 4.37 | 46160211 | |
173 | Ubiquitination | SGREITWKDFVNNYL CCCCCCHHHHHHHHH | 32.41 | 21890473 | |
179 | Phosphorylation | WKDFVNNYLSKGVVD HHHHHHHHHCCCCHH | 13.72 | 22817900 | |
182 | Ubiquitination | FVNNYLSKGVVDRLE HHHHHHCCCCHHHHH | 53.80 | 21890473 | |
193 | Ubiquitination | DRLEVVNKRFVRVTF HHHHHCCCCEEEEEE | 35.29 | - | |
193 | Acetylation | DRLEVVNKRFVRVTF HHHHHCCCCEEEEEE | 35.29 | 30585747 | |
193 | 2-Hydroxyisobutyrylation | DRLEVVNKRFVRVTF HHHHHCCCCEEEEEE | 35.29 | - | |
218 | Phosphorylation | YVWFNIGSVDTFERN EEEEEECCHHHHHHH | 17.02 | 46160187 | |
221 | Phosphorylation | FNIGSVDTFERNLET EEECCHHHHHHHHHH | 25.82 | 46160199 | |
270 | Phosphorylation | IIAFLLYTIRRGPAG HHHHHHHHHHHCCCC | 14.15 | 24719451 | |
285 | Sulfoxidation | IGRTGRGMGGLFSVG CCCCCCCCCCCEECC | 3.56 | 21406390 | |
290 | Phosphorylation | RGMGGLFSVGETTAK CCCCCCEECCHHHHH | 33.97 | 22210691 | |
300 | Acetylation | ETTAKVLKDEIDVKF HHHHHHHHHHCCCCC | 57.19 | 26051181 | |
300 | Ubiquitination | ETTAKVLKDEIDVKF HHHHHHHHHHCCCCC | 57.19 | - | |
306 | Acetylation | LKDEIDVKFKDVAGC HHHHCCCCCCCCCCC | 42.84 | 19608861 | |
308 | Succinylation | DEIDVKFKDVAGCEE HHCCCCCCCCCCCHH | 45.64 | 27452117 | |
308 | Acetylation | DEIDVKFKDVAGCEE HHCCCCCCCCCCCHH | 45.64 | 26051181 | |
308 | Malonylation | DEIDVKFKDVAGCEE HHCCCCCCCCCCCHH | 45.64 | 30639696 | |
331 | Succinylation | VNFLKNPKQYQDLGA HHHHHCHHHHHCCCC | 71.66 | 23954790 | |
331 | Ubiquitination | VNFLKNPKQYQDLGA HHHHHCHHHHHCCCC | 71.66 | - | |
331 | 2-Hydroxyisobutyrylation | VNFLKNPKQYQDLGA HHHHHCHHHHHCCCC | 71.66 | - | |
331 | Malonylation | VNFLKNPKQYQDLGA HHHHHCHHHHHCCCC | 71.66 | 26320211 | |
331 | Acetylation | VNFLKNPKQYQDLGA HHHHHCHHHHHCCCC | 71.66 | 25953088 | |
342 | Ubiquitination | DLGAKIPKGAILTGP CCCCCCCCCCEEECC | 65.53 | 21890473 | |
352 | Phosphorylation | ILTGPPGTGKTLLAK EEECCCCCCHHHHHH | 41.08 | 110761159 | |
354 | Ubiquitination | TGPPGTGKTLLAKAT ECCCCCCHHHHHHHH | 35.52 | - | |
402 | Glutathionylation | LARKNAPCILFIDEI HHHCCCCEEEEEEEC | 3.81 | 22555962 | |
425 | Phosphorylation | RGNFGGQSEQENTLN CCCCCCCCHHHHHHH | 44.51 | 24043423 | |
430 | Phosphorylation | GQSEQENTLNQLLVE CCCHHHHHHHHHHHH | 26.74 | 24043423 | |
443 | Phosphorylation | VEMDGFNTTTNVVIL HHCCCCCCCCCEEEE | 32.51 | 24043423 | |
444 | Phosphorylation | EMDGFNTTTNVVILA HCCCCCCCCCEEEEE | 19.92 | 24043423 | |
445 | Phosphorylation | MDGFNTTTNVVILAG CCCCCCCCCEEEEEC | 24.79 | 24043423 | |
453 | Phosphorylation | NVVILAGTNRPDILD CEEEEECCCCCCCCC | 23.58 | 24043423 | |
481 | Malonylation | FIGPPDIKGRASIFK EECCCCCCCCCEEEE | 50.12 | 26320211 | |
481 | Ubiquitination | FIGPPDIKGRASIFK EECCCCCCCCCEEEE | 50.12 | 21890473 | |
485 | Phosphorylation | PDIKGRASIFKVHLR CCCCCCCEEEEEEEC | 27.48 | 24719451 | |
488 | Malonylation | KGRASIFKVHLRPLK CCCCEEEEEEECCCC | 27.37 | 26320211 | |
498 | Phosphorylation | LRPLKLDSTLEKDKL ECCCCCCCHHHHHHH | 45.38 | 24670416 | |
502 | Succinylation | KLDSTLEKDKLARKL CCCCHHHHHHHHHHH | 64.37 | 27452117 | |
502 | Acetylation | KLDSTLEKDKLARKL CCCCHHHHHHHHHHH | 64.37 | 26051181 | |
502 | Malonylation | KLDSTLEKDKLARKL CCCCHHHHHHHHHHH | 64.37 | 26320211 | |
504 | Malonylation | DSTLEKDKLARKLAS CCHHHHHHHHHHHHH | 55.93 | 26320211 | |
508 | Ubiquitination | EKDKLARKLASLTPG HHHHHHHHHHHCCCC | 42.68 | - | |
543 | Malonylation | LSDSINQKHFEQAIE HCHHHCHHHHHHHHH | 45.86 | 26320211 | |
543 | Acetylation | LSDSINQKHFEQAIE HCHHHCHHHHHHHHH | 45.86 | 23954790 | |
543 | Ubiquitination | LSDSINQKHFEQAIE HCHHHCHHHHHHHHH | 45.86 | 21890473 | |
558 | Malonylation | RVIGGLEKKTQVLQP HHHHHHHHHCEECCH | 67.19 | 26320211 | |
558 | Ubiquitination | RVIGGLEKKTQVLQP HHHHHHHHHCEECCH | 67.19 | - | |
558 | 2-Hydroxyisobutyrylation | RVIGGLEKKTQVLQP HHHHHHHHHCEECCH | 67.19 | - | |
559 | 2-Hydroxyisobutyrylation | VIGGLEKKTQVLQPE HHHHHHHHCEECCHH | 34.51 | - | |
559 | Malonylation | VIGGLEKKTQVLQPE HHHHHHHHCEECCHH | 34.51 | 26320211 | |
559 | Succinylation | VIGGLEKKTQVLQPE HHHHHHHHCEECCHH | 34.51 | 27452117 | |
560 | Phosphorylation | IGGLEKKTQVLQPEE HHHHHHHCEECCHHH | 34.67 | 46160205 | |
568 | Acetylation | QVLQPEEKKTVAYHE EECCHHHHCCEEEHH | 52.67 | 26051181 | |
611 | Acetylation | GYAQYLPKEQYLYTK CCHHCCCHHHHCCCH | 55.65 | 26051181 | |
611 | Ubiquitination | GYAQYLPKEQYLYTK CCHHCCCHHHHCCCH | 55.65 | 21890473 | |
614 | Phosphorylation | QYLPKEQYLYTKEQL HCCCHHHHCCCHHHH | 11.63 | 110761165 | |
618 | Ubiquitination | KEQYLYTKEQLLDRM HHHHCCCHHHHHHHH | 29.88 | - | |
618 | 2-Hydroxyisobutyrylation | KEQYLYTKEQLLDRM HHHHCCCHHHHHHHH | 29.88 | - | |
624 | Methylation | TKEQLLDRMCMTLGG CHHHHHHHHHHHHCC | 21.85 | - | |
634 | Phosphorylation | MTLGGRVSEEIFFGR HHHCCCCCCHHCCCC | 28.31 | 20068231 | |
689 | Phosphorylation | DMVLEKPYSEATARL CEEEECCCCHHHHHH | 30.15 | 20068231 | |
690 | Phosphorylation | MVLEKPYSEATARLI EEEECCCCHHHHHHC | 29.31 | 20068231 | |
693 | Phosphorylation | EKPYSEATARLIDDE ECCCCHHHHHHCCHH | 14.30 | 20068231 | |
710 | 2-Hydroxyisobutyrylation | ILINDAYKRTVALLT HHHCHHHHHHHHHHH | 43.23 | - | |
710 | Acetylation | ILINDAYKRTVALLT HHHCHHHHHHHHHHH | 43.23 | 25953088 | |
710 | Succinylation | ILINDAYKRTVALLT HHHCHHHHHHHHHHH | 43.23 | 27452117 | |
712 | Phosphorylation | INDAYKRTVALLTEK HCHHHHHHHHHHHCC | 13.13 | 20068231 | |
719 | 2-Hydroxyisobutyrylation | TVALLTEKKADVEKV HHHHHHCCCCCHHHH | 48.29 | - | |
725 | 2-Hydroxyisobutyrylation | EKKADVEKVALLLLE CCCCCHHHHHHHHHH | 32.43 | - | |
738 | Ubiquitination | LEKEVLDKNDMVELL HHHHHCCCCCCHHHH | 51.16 | - | |
763 | Phosphorylation | YEEFVEGTGSLDEDT HHHHHCCCCCCCCCC | 15.30 | 26471730 | |
765 | Phosphorylation | EFVEGTGSLDEDTSL HHHCCCCCCCCCCCC | 32.27 | 28857561 | |
770 | Phosphorylation | TGSLDEDTSLPEGLK CCCCCCCCCCCCHHH | 30.07 | 28857561 | |
771 | Phosphorylation | GSLDEDTSLPEGLKD CCCCCCCCCCCHHHH | 55.00 | 28348404 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AFG32_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AFG32_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AFG32_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
AT1A1_HUMAN | ATP1A1 | physical | 26344197 | |
ATPA_HUMAN | ATP5A1 | physical | 26344197 | |
PHB_HUMAN | PHB | physical | 26344197 | |
PHB2_HUMAN | PHB2 | physical | 26344197 | |
RPN1_HUMAN | RPN1 | physical | 26344197 | |
TMCO1_HUMAN | TMCO1 | physical | 26344197 | |
QCR8_HUMAN | UQCRQ | physical | 26344197 |
Kegg Disease | |
---|---|
H00063 | Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3) |
H00473 | Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency ( |
OMIM Disease | |
610246 | Spinocerebellar ataxia 28 (SCA28) |
614487 | Spastic ataxia 5, autosomal recessive (SPAX5) |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00171 | Adenosine triphosphate |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-306 AND LYS-543, AND MASSSPECTROMETRY. |